Disease-modifying therapy for multiple sclerosis: Implications for gut microbiota
Silvy Pilotto, Magdalena Żołędziewska, Giuseppe Fenu, Eleonora Cocco, Lorena Lorefice
Topics & Concepts
NatalizumabFingolimodMultiple sclerosisGlatiramer acetateMedicineMicrobiomeAlemtuzumabTeriflunomideImmunologyGut floraDysbiosisDiseaseInternal medicineBioinformaticsBiologyAntibodyGut microbiota and healthMultiple Sclerosis Research StudiesImmune responses and vaccinations